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resumo 
 
 
O óxido de grafeno (GO) é um composto com aplicação em diversas áreas, 
especialmente biomedicina e ambiente, devido as suas propriedades únicas que 
lhe conferem excelentes características. Apesar da atual ampla utilização de 
nanomateriais, a falta de informação sobre os riscos para a saúde humana e para 
o ambiente ainda permanece. Consequentemente, a investigação sobre a 
toxicidade das nanopartículas deve ser uma prioridade. Sendo o pulmão uma das 
principais vias de entrada das nanopartículas no organismo, o objetivo deste 
trabalho é avaliar o potencial citotóxico de óxido de grafeno no pulmão, usando 
com modelo uma linha celular epitelial de carcinoma do pulmão humano (A549). A 
morfologia e a viabilidade das células A549 foram avaliados após 24 horas de 
exposição a concentrações de GO entre 10µg/mL a 200µg/mL. A captação de GO 
e a produção de espécies reativas de oxigênio foram avaliadas por citometria de 
fluxo. Os resultados sugerem que GO não apresenta óbvia toxicidade para as 
células A549, quando avaliada pelo ensaio WST-8. No entanto, no ciclo celular 
observou-se uma ligeira alteração na fase S e na fase G2 em 50µg/mL, com 
paragem na fase G2. GO induziu também um aumento na produção de ROS em 
doses mais baixas (10µg/mL e 37µg/mL). A captação intracelular de GO aumentou 
para a dose mais elevada. Em conjunto, estes resultados sugerem que esta forma 
de GO apresenta biocompatibilidade para as células de pulmão. 
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abstract 
 
Graphene oxide (GO) is a compound with application in several fields, especially 
biomedicine and environment, due to its unique properties which confer excellent 
characteristics. Despite the nowadays wide application of nanomaterials, the lack 
of information regarding the risks to human health and the environment is still 
remaining. Consequently, the investigation about the toxicity of nanoparticles must 
be a priority. The lung is one of the main routes of entry for nanoparticles into the 
body, therefore, the aim of this study is to evaluate the cytotoxic potential of 
graphene oxide in lung, using as model the human carcinoma epithelial cell line 
(A549). The morphology and viability of A549 cells were evaluated after 24h of 
exposure to GO at concentrations from 10µg/ml to 200µg/ml. The uptake of GO 
and the production of reactive oxygen species were also investigated by flow 
cytometry. The results suggest that GO has no obvious toxicity to A549 cells when 
assessed by WST-8 assay, though the cell cycle showed a slightly alteration in the 
S and G2 phase at 50µg/mL with arrest at G2 phase. Also, GO showed an 
increasing in the ROS production at the lowest doses (10ug/mL and 37µg/mL). The 
intracellular uptake increased for the highest concentration. Together these results 
suggest that this form of GO shows biocompatibility for lung cells. 
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I. Introduction 
I.1 Nanoscience  
Nanoscience and nanotechnology are placed in the greater technological area, as the 
science has advanced throughout the time in many areas, the “nano” field also has evolved 
and expanded quickly. Attention has been driving to this field as long as the nanomaterials 
have shown great potential application in several areas of science ranging from medicine, food 
processing, to energy production and storage, and electronics (Agrawal, 2013). This promising 
field deals with materials with structures that reveal distinctive physical, chemical and biological 
properties due to their nanoscale. They have unique optical, magnetic, and mechanical 
properties and a large surface area (Beer et al., 2012).  
Nanomaterials are defined by the International Organization for Standardisation - IOS, 
as a natural, incidental or manufactured material containing particles with at least one of its 
dimensions at 100nm or less (European Commission, 2011). Nanoparticles are also classified 
based on their dimensionality (1D, 2D or 3D), morphology, composition, uniformity and 
agglomeration. Nanoparticles may be formed naturally through numerous physical processes 
from erosion to combustion, whereby this leads to health risks reaching from harmful to benign 
responses (Buzea et al., 2007). The use of nanoparticles has facilitated the emergence of 
innovative products in areas such as electronic, medicine, biotechnology, industry, among 
others (Ai et al., 2011). With this large spectrum of application, the nanoscience might reach 
the common industry with products with more efficacy, quality, more environmental sustainable 
and maybe less cost. 
The work in nanoscience and nanotechnology has also brought new perspectives to 
overcoming challenges at the nano scale. As more approaches from different areas of research 
have worked in this field, the possibility of those variable nanomaterials be more available in a 
common society has also increased. This process leads to an essential matter, the safety level 
of nanomaterials. 
I.2 Nanotoxicology 
Despite the promising future of the nanomaterials, it is known that its use brings risks 
and potential harmful impacts on human health and the environment. The physical and 
chemical properties of NPs have been recognized as the main reason for the impact in the 
biological and toxicological activity. As the table 1 shows, there are many physico-chemical 
properties of relevance for toxicology properties and their measurement are important for the 
  
2 
 
understanding of toxicological results (Oberdorster, 2010). As a major issue, an assessment 
of the toxicological and ecotoxicological risks should take into account these properties, 
especially in regard to the nanomaterial production when considered at the industrial level (Ai 
et al., 2011; Buzea et al., 2007). There is a great development in the biomedical context, where 
the nanoparticles with their unique properties and features can have high application in the 
biomedical field. However, is important to mention once more the potential adverse effects that 
are unknown in the use of nanoparticles (Fadeel et al., 2010; Oberdorster, 2010). With the lack 
of information, many questions arise about the interaction of nanoparticles with biological 
systems. Despite nanomedicine advances in diagnostic and therapeutic systems, the potential 
effect on human health due to constant exposure to nanomaterials has not been completely 
unveiled (Cancino et al., 2014; Pyrrho and Schramm, 2012), therefore, systematic evaluations 
of the potential toxicity of nanomaterials should be urgently conducted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nanotoxicology is proposed as a new subject in the toxicology area to investigate 
specifically the adverse effects caused by nanomaterials on the way to contribute to the 
development of a sustainable and safe technology (Donaldson et al., 2004). Understanding the 
characteristics such as dispersion, accumulation, stability and agglomeration level becomes 
essential to characterize the nanoparticle in order to meet its biocompatibility (Ai et al., 2011). 
Likewise, obtained knowledge will perform an important part in efficacy, safety and regulatory 
consent for materials, diagnostics and therapeutics. 
Physico-chemical NPs properties of relevance for toxicology 
Size (airborne, hydrodynamic)  
Size distributions  
Shape  
Agglomeration/aggregation Properties can change 
Surface properties 
o Area (porosity) 
o Charge 
o Reactivity 
o Chemistry (coatings, 
contaminants) 
o Defects 
 with method of production 
preparation process storage. 
 when introduced into physio, 
media, organism. 
Solubility (lipid, aqueous, in vivo) 
 
Crystallinity  
Table 1. Physico-chemical NP properties of relevance for toxicology. Adapted from 
Oberdörster, 2010. 
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I.3 Graphene Nanoparticles  
I.3.1 Graphene Overview 
Graphene is a two-dimensional carbon crystal composed of a single layer and 
hexagonally arranged carbon atoms. The assembling of its layers constitute the graphite that 
is a material existing in nature. In 2010 the Nobel Prize in Physics was given to two researchers 
Konstantin Sergeevich Nonoselov and Andre Geim Konstantinov both from University of 
Manchester, who successfully isolated for the first time in 2004 the material in its free state by 
a mechanical exfoliation from graphite crystal (Geim and Novoselov, 2007; Novoselov et al., 
2004). Since there, studies with graphene and its derivatives were intensified and unique 
properties were discovered.  
Theoretically, the material has been studied for a long period, however in practical ways, 
just in 2004 after the efficient isolation of graphene by (Novoselov et al., 2004), it came a 
flourishing time to graphene. Assuming the discovering of the very exclusive properties of 
graphene, it may be highlighted: the large surface area; chemical and mechanical stability; high 
electrical and thermal conductivity; and good biocompatibility (Geim, 2009; Kuila et al., 2012; 
Liu et al., 2013), all these features have given more focus to the material to be applied in many 
areas of science (Figure 1). 
 
 
Sanchez et al. 2013 proposed a systematic nomenclature for the derivatives of 
graphene as Graphene-Family Nanomaterials (GFNs) and those materials are: few-layer 
graphene (FLG), graphene oxide (GO), reduced graphene oxide (rGO), ultrafin graphite, and 
Figure 1. General properties of graphene on the left hand side and the main application areas of graphene on the right hand 
side (Liu et al., 2013; Nguyen and Zhao, 2014; Sun et al., 2008). 
Biological 
applications 
Eletrochemical
biosensing, 
bioimaging
Drug delivery
Electronic 
applications
Transparent 
conducting 
films
Energy 
harvesting and 
storage
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graphene nanosheets (GNS), (Sanchez et al., 2013). The scope of areas which GFNs can be 
applied, its ranging from nano-electronic to biomedical field and those nanoparticles have 
attracted a vast interest both in academics and industry. It is also known that all the unique 
properties of graphene, are associated with its individual sheet (Kuila et al., 2012; Li et al., 
2008), however so many difficulties have been found to produce a functionalized single-layer 
graphene in bulk scale. The main reason is the aggregation/agglomeration tendency (Kuila et 
al., 2012) of its layers for the presence of hydrophobic nature (Kiew et al., 2016) nonetheless, 
many studies have been done to find a way to overcome this challenge (Li et al., 2008; Zhang 
Liu et al., 2008; Shan et al., 2009).  
Over the years, GO has become a favourite graphene’s derivative for the 
functionalization of graphene, mainly regard the solubility that is limited by graphene and in 
part for GO. Once the graphene is highly hydrophobic and does not have oxygen-containing 
groups as the GO owns, this confers to GO a better dispersion in water solution that represent 
a potential in the medicine and industry applications. In spite of the solubility of GO in water, it 
exhibits aggregation in variable mediums (Liu et al., 2013; Zhang et al., 2016; Zhou and Gao, 
2014). 
I.3.2 Graphene Oxide Description 
Graphene oxide material consists of single-atom-thick carbon sheets with hydrophilic 
peripheral groups (carboxylate groups) that offer colloidal stability. In the basal surface, GO 
also shows uncharged polar groups (hydroxyl and epoxide) as well is found hydrophobic 
graphenic domains and capable of π-π interactions for drug loading and others 
functionalization (Cote et al., 2010; Park et al., 2009) (Figure 2). Above all, these groups allow 
this material to be functionalized by covalent and non-covalent methods (Dreyer et al., 2009). 
All this structure makes GO as an amphiphilic sheet-like molecule, which can show an excellent 
Figure 2. Structure of graphene, graphene oxide and reduced graphene oxide. Adapted from 
Perreault et al., 2015. 
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ability as surfactant, used to stabilize hydrophobic substances in water solutions (Cote et al., 
2010). 
GO as a highly oxidized form of a modified graphene, might contain not only monolayers 
but multilayer flakes, for that reason is required a complete characterization of the material 
(Sanchez et al., 2013) to guarantee a systematic and comprehensive study. Moreover, the 
variation of the material such as the characteristic in number of layers, size, chemical structures 
are already recognized to be involved in the toxicity of the material likewise, the different 
methods of producing graphene oxide (Lay et al., 2013; Seabra et al., 2014). 
Nowadays GO can be easily prepared and the most common method is the procedure 
described by Hummers and Offeman, 1958. There are four main used methods to produce 
GO: Hoffman; Staudenmaier; Tour; and Hummers; all these methods use different oxidative 
methods of graphite to GO preparation and generally they all produce GO with similar 
properties (figure 3). From the idea of this variation on the oxidative conditions, it is expected 
the difference among the amounts of oxygen functionalities present on GO (Dreyer et al., 2009; 
Lay et al., 2013). 
 
 
 
 
 
I.3.3 Application of Graphene Oxide  
Graphene oxide, as a prominent derivative of graphene, has hold numerous and 
promising advantages in different areas, including electronic, mechanical, medical and 
environmental fields (Liu et al., 2013; Sun et al., 2008). Regarding the potential of GO, a 
number of groups have dedicated their efforts to GO-based materials. 
Figure 3. Production of Graphene Oxide from oxidative methods on graphite material. Scheme adapted 
from Lay et al., 2013.  
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In the biomedical and environmental field, GO has been increasingly used showing great 
potential and promising results. For example, in biomedical application GO has been studied 
as an excellent drug-delivery, when in a pioneer work (Zhuang Liu et al., 2008) it was used 
polyethylene glycol (PEG) associated with GO, as a nanocarrier of a water-insoluble anticancer 
drugs and their results revealed a superior increase on the solubility and a great anticancer 
efficacy with the camptothecin analog SN38 drug. In another study, GO demonstrated to be a 
good carrier of doxorubicin (DOX) into cancer cells, once this drug is well known to have a 
potential anticancer agent, also is related with some adverse effects when used by itself. 
However, this association DOX-GO, was suggested to be used for therapeutic purpose (Yang 
et al., 2008); also for treatment of drug-resistant cancers, as it was found when anthracycline 
antibiotic (ADR) was loaded onto GO and this association showed a greater effect against 
breast cancer cells (MCF-7), which cells are known to be resistant to ADR by itself (Wu et al., 
2012). Moreover, GO has shown potential for loading different molecules beyond GO-DOX, 
which has been extensively studied (Lv et al., 2016; A. J. Shen et al., 2012; Yang et al., 2008), 
but also with small molecules such as proteins, where GO-PEG was related for the first time 
to be used as an very effective nanovector for delivery proteins into cells, being used as a 
protection to avoid the protein to be hydrolysed enzymatically (H. Shen et al., 2012), still GO is 
related to be associated with peptides (Shim et al., 2015) and nucleic acids (Lu et al., 2009). 
As other ways to apply GO in the biomedical field, instead of drug-loading or nanocarrier there 
are also studies relating great potential in bioanalysis; disease-related diagnostics, near-
infrared phototherapy and imaging (Feng et al., 2013; Shi et al., 2014). 
The applications of GO in the environment have been also increasing. Studies related 
to the application of the nanomaterial directly, for example in 2013 was found that GO would 
be stable in an aquatic environment (Chowdhury et al., 2013), also GO was investigated in a 
way to create a biofoam to clean dirty water and this promising method combines bacteria-
produced cellulose and GO to form a bilayered biofoam (Jiang et al., 2016) another method 
combines a foam GO-made, that was able to remove very effectively toxic pollutants as 
Mercury from water (Henriques et al., 2016). Overall, GO remains unclear and has to be 
explored in many ways. With the great potential of GO in a very wide future, it is needed to 
investigate its interaction with different cell types that are in the body and likely to interact with 
foreign materials. 
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I.3.4 Potential for Human Exposure 
All those properties of GO contribute to increase the use of graphene and its derivatives 
making them available directly or indirectly in the environment and biological systems. The 
possibility of release the nanoparticles in a variable environment, may be accidentally or on 
purpose reach the human body, cause a serious matter where the toxic effect/response in 
biological systems must be emphasized (Figure 4). A systematic analysis of the potential 
hazards of graphene and its derivatives is required to be done, as Golkaram, 2015 says carbon 
based material are either biocompatible or have insignificant toxic effect (Golkaram and van 
Duin, 2015) but until today it is little known about graphene compared with other carbon 
nanostructure (Sanchez et al., 2013; Seabra et al., 2014).  
The knowledge about biocompatibility and toxicity level that graphene or any other 
nanomaterial might reach in biological system, is important to reach to a degree of safety to its 
uses. Basically there are four routes to human exposure to nanoparticles: inhalation, 
intravenous, dermal and oral (Buzea et al., 2007; Love et al., 2012; Sanchez et al., 2013). 
Therefore, the main routes of exposure in humans is through the skin, lungs, and the 
gastrointestinal tract. As graphene materials are usually synthezised as dry powders, the 
inhalation of the material become a significant route to human expose. The nanomaterial 
absorption through the several tissues on a biological system may vary, showing a high 
dependence of the portal of entry and the particle size(Oberdörster et al., 2005) (Figure 5).  
Figure 4. Scheme of general possibility of nanoparticles (NPs) reach the human body.  
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I.4 Nanotoxicity studies 
Understanding the potential risks and human impact that are present in the exposure to 
nanomaterials is the main key for nanotoxicology. This matter leads to an investigation with 
quantification and visualization methods of nanomaterials in vitro and in vivo that must be 
performed with reliable data, trustful tests and protocols (Donaldson et al., 2004). The 
assessment in nanotoxicology goes above the investigation of routes of exposure, 
biodistribution, physicochemical and molecular determinants, genotoxicity among other 
aspects (Donaldson et al., 2004; Lewinski et al., 2008). The main components of risk 
assessment are the effect and exposure, where the dose-response, bioavailability and 
bioaccumulation are covered.   
The toxicity studies may be divided in different categories: in vivo, in vitro, in silico and/or 
environmental studies. The most common approaches performed are in vitro and in vivo 
studies (Zhou and Gao, 2014). The in vitro approach presents some advantages for studying 
cytotoxicity: as the capacity to determine the primary effects of nanoparticles on target cells, 
the efficiency, quickness and low cost. On the other way, the in vivo study, can take a huge 
advantage to in vitro method since the observation can be performed in a complex organism, 
Figure 5. Absorption of Nano-sized particles. Showing routes of exposures, the main uptake pathways, metabolism and excretion of NPS 
(Oberdörster et al., 2005). 
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allowing a comparison with the human organism, for example. Still, in vivo method must be 
conducted with monitored parameters, such as: weight change, gastrointestinal function, 
imaging procedures, mortality, clinical pathology and so on. As much parameters be analysis, 
more information about the nanoparticles interaction with a complex organism is extracted from 
the experiment (Adjei et al., 2014). Concerning the in vivo experimentation, the ethical approval 
also is mandatory, despite the existence of various legislature around the world (European 
Union, 2010) they all aim to comprehend the “3Rs”: designated by replace, reduce and refine 
which refers to the use of animals for scientific purposes. As proposed by Russell and Burch’s 
the “3Rs”, the replace means the substitution for conscious living higher animals of insentient 
material. Reduction means reduction in the numbers of animals used to obtain information of 
a given amount and precision. Refinement means any decrease in the occurrence or severity 
of inhumane procedures applied to those animals which still have to be used (Russell and 
Burch, 1959). 
I.5 Toxicity and biocompatibility 
As a first step to evaluate the health risks related with nanomaterials, an in vitro testing 
is recommended to investigate the nanoparticle cytotoxicity. The toxicity of GO has also been 
shown by a number of in vitro studies (Chang et al., 2011; Fiorillo et al., 2015; Lay et al., 2013; 
Liao et al., 2011) and yet it is not clear the degree of the toxicity of GO. Chang et al. (2011) 
suggested that no obvious toxicity in A549 cell line, however is observed the influence of the 
nanomaterial size, with the ability to increase the ROS production, it was also confirmed that 
beyond the size, the shape and aggregation might affect the uptake on the cells (Chang et al., 
2011). Another study by Liao and co-workers (2011) reported that even with different cell lines 
the level of ROS is dose-dependence. A strong dose-dependence is associated with the 
cytotoxic response (Lay et al., 2013). Additionally it was demonstrated that GO may also 
confers a selected inhibition to the proliferative expansion of cancer stem cells, Fiorillo et al., 
2015 mention that GO treatment, targeted several different signal transduction pathways, 
reducing overall “stemness”. Taking all into account the applications of GO, a consistent level 
of studies about the toxicity and human safety level are required (Seabra et al., 2014). Thus 
wide in vitro and in vivo studies are essential to explore the biocompatibility and toxicity of the 
nanomaterial, allowing this way the safe use of GO in clinical applications (Liu et al., 2013). 
The limited literature on in vitro toxicity suggests that GFNs can be either benign or toxic 
to cells, and it is hypothesized that the biological response will vary across the material family 
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depending on layer number, lateral size, stiffness, hydrophobicity, surface functionalization, 
and dose (Sanchez et al., 2013). 
The inhalation route becomes a very significant route to explore, considering the human 
expose, because of the fact that mostly NPs might entry in the biological system through this 
route. Inhaled NPs are usually considerably deposited in the human respiratory tract, the 
distribution, as well as the way of excretion of NPs have been widely studied, among others 
routes (Figure 5). However, their toxic potential may depend the nanoparticle physico-chemical 
characteristics (Itoh et al., 2004; Sanchez et al., 2013). Moreover, the damage caused by 
particle deposition may affect the lung defence and clearance leading to formation of 
granulomas and lung fibrosis (Card et al., 2008; Itoh et al., 2004). It is also noticed throughout 
the studies, that in vitro cytotoxicity studies of nanoparticles commonly use different cell lines, 
with variation in incubation times, also a wide range of nanoparticles concentrations are 
chosen, with different exposure times. All these features make in some way a problem to 
determinate whether the cytotoxicity observed is physiologically pertinent, and also make a 
really difficult study to compare the investigations with all these variations (Lewinski et al., 
2008). 
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II. Principles of methods employed 
II.1 Characterization of Nanomaterials 
Different techniques currently are used to determine the nanoparticle size distribution, 
concentration and composition in diverse samples. To properly characterize nanoparticles, a 
number of techniques are recommended such as, UV-Visible Spectroscopy, Dynamic Light 
Scattering (DLS), Centrifugal Liquid Sedimentation (CLS) Nanoparticle Tracking Analysis 
(NTA) as well as electron microscopy (EM) techniques (Braakhuis et al., 2015) on the way to 
allow the possibility to visualize the particle shape and morphology. EM is used to characterize 
nanoparticles, through Scanning Electron Microscopy (SEM) and Transmission Electron 
Microscopy (TEM) assays, the average size and size distributions can be measured and 
calculated by specific software program. 
The DLS is a widely used method that uses laser diffraction with multiples scatterings, 
and can be used to determine the hydrodynamic diameter, as well as the respective 
agglomeration, in various mediums. DLS is very dependent on the polydispersity of the 
nanoparticle suspension and also to the material properties of the particles once the scattered 
light of the individual particles must be strong enough for detection (Chen et al., 2013). This 
technique allows to measure the size distribution or the average size of molecules and particles 
dispersed or dissolved in a liquid (Braun et al., 2011).  
II.2. In vitro toxicity assessment 
There are a number of approaches to assess the in vitro toxicity of a nanomaterial, most 
of them examine on a single, homogeneous, immortal cell type, in a way to reproduce an 
exposure route on a biological organism, a cell type is chosen. Also, there are two categories 
to assess nanoparticles toxicity which are the functional assays and viability assays (Love et 
al., 2012). Frequently, the most of the assays start assessing the viability of cells, while there 
are others such as, membrane integrity, uptake, oxidative stress, genotoxicity etc. (Kroll et al., 
2009; Love et al., 2012). 
II.2.1 Cell line and treatment  
Considered as an in vitro model for type II lung epithelium human cells, A549 cells are 
commonly employed in lung toxicity assays and has been well-characterized (Foster et al., 
1998; Lieber et al., 1976). While the inhalation exposure route is among the most commonly 
direct way of nanoparticles reach an organism, correlated studies are held in variable assays 
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such as cell viability and uptake focusing mainly in immortal lung cell lines (Love et al., 2012). 
The A549 cell line was established in 1972 by D.J. Giard, et al. and it is originated from a 
Caucasian male, 58 years old, diagnosed with lung adenocarcinoma (Giard et al., 1973). These 
cells among many features, have the ability to synthesize proteins immunologically related to 
human surfactant-associated glycoproteins - HSAG (Balis et al., 1984); they also synthetize 
lecithin (act as a surfactant) with high percentage of disaturated fatty acids (Lieber et al., 1976).  
A549 when cultured in vitro, growths as an adherently monolayer, show multilamellar 
cytoplasmic inclusions bodies commonly found in type II lung epithelium human cells (Forbes 
and Ehrhardt, 2005; Foster et al., 1998; Lieber et al., 1976). When the cells reached the desired 
confluence on the culture flask to the experiment, they should be submitted to the standard 
process of detachment, trypsinization. Trypsinization is often used to allow passages or for 
observation of experimentation. The process of cell dissociation uses trypsin, a proteolytic 
enzyme to unattached cells from the flasks surface, breaking down proteins (Huang et al., 
2010). 
II.2.2 Cell Viability 
Cell viability is commonly evaluated by using tetrazolium reduction based assays, as 
well as through the assessment of cell membrane integrity. Among the tetrazolium reduction 
based assays, the  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide – MTT is the 
most commonly used assay to determine cell viability, the principle is mitochondrial activity-
based. Other related tetrazolium dyes include the Water-Soluble Tetrazolium salts, as for 
instance the – WST-8 that works on the same principle but instead of been positive charged 
as MTT, and therefore able to penetrate viable cells, WST-8 is negatively charged and then 
not readily penetrates cells. The main difference between the MTT and WST-8 assays, is 
based on the involved enzymes and solubility. While the WST-8 is water-soluble and the 
enzymes used are the most of the dehydrogenases, the MTT assay uses only the mitochondria 
dehydrogenase. WST-8 is reduced by dehydrogenases in cells to give an orange-coloured 
Figure 6. Principle of cell viability detection by WST-8 assay. The WST-8 reagent is added to cells and the electron mediator receives 
electrons from a viable cell (NADH enzyme) and transfers the electron to WST-8 in the culture medium which is reduced, resulting in an 
orange-coloured product (formazan).  
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product (formazan), which is soluble in the tissue culture medium (Figure 6). The amount of 
the formazan dye generated by dehydrogenases in cells is directly proportional to the number 
of living cells. WST-8 also does not produce crystals like MTT does, and is achieved by simple 
steps it determines faster and efficiently viable cell with stability and security.  
 The WST-8 and MTT solution are colourless, while the result is formazan, a well-stained 
solution (Held, 2009).The result of MTT is given by a purple formazan in living cell, differently in 
the WST-8 where the results in a yellow-orange dye. As a recommendable assay, WST-8 is not 
cytotoxic in the cell culture medium, allowing other test to be done in the same used plate.  
Additionally, cell membrane integrity is generally evaluated by the lactate 
dehydrogenase leakage assay – LDH, and has been used to determine the cytotoxicity of 
several nanoparticles (Braydich-Stolle, 2005; Chen et al., 2015; Zhang et al., 2012). This assay 
is based on the amount of lactate dehydrogenase activity in the extracellular medium, the loss 
of intracellular LDH, demonstrates the cell death due to cell membrane injury (Fotakis and 
Timbrell, 2006). 
Among others assays, there are those that exclude various dye compounds such as 
Trypan blue, a widely used assay for staining dead cells. In this method, cell viability is 
determined by counting the unstained cells with a microscope, yet this assay is commonly used 
to complement others viability assays but somehow is limited, because cannot be used to 
distinguish healthy cells from others nonhealthy but still alive cells (Liao et al., 2011; Mbeh et 
al., 2014). Neutral Red (NR) assay, which is also used to measure cell viability is considered a 
useful assay to detect lysosomal damage, but is suggests to be used complementally with 
other tests, as a colorimetric assay, it determines the accumulation of NR dye in the lysosomes 
of viable and uninjured cells (Fotakis and Timbrell, 2006).  
II.2.3 Reactive Oxygen Species  
The Reactive Oxygen Species (ROS) production can be assessed by various methods 
but the most widely used are based in permeable fluorescent and chemiluminescent probes 
(Eruslanov and Kusmartsev, 2010).  The fluorescent probe chosen to this work was the 2′-7′-
Dichlorodihydrofluorescein diacetate (DCFH2-DA) which is commonly used to measure the 
redox state of a cell. This probe has several advantages as for instance, is extremely sensitive 
to changes in the cell redox state, is inexpensive and can be used to follow changes in ROS 
over time (Royall and Ischiropoulos, 1993). The probe DCFH2-DA, enters the cells and is 
deacetylated by cellular esterases producing non-fluorescent DCFH2 and diacetate. In the 
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cytosol DCFH2 is quickly oxidized to fluorescent DCF by intracellular ROS (Eruslanov and 
Kusmartsev, 2010; Royall and Ischiropoulos, 1993). 
II.2.4 Cell cycle analysis 
Cell cycle is the biological process and involves different phases. The proliferation of the 
cells includes four different phases: G1 phase, where the growth and preparation of the 
chromosomes happens for the replication; S phase, the synthesis of the DNA take place and 
the centrosome is duplicate; G2 phase, is the preparation for Mitosis, which is the final phase 
(M phase) (Nunez, 2001). Also the cell cycle is regulated on the way to achieve a normal 
development and to protect the genomic integrity, the regulation process is called cell cycle 
checkpoints, where several proteins are involved in this process (Bork et al., 2011; Hartwell 
and Weinert, 1989; Koren, 2007) (Figure 7).  
Cell cycle is commonly analysed by flow cytometry (FCM), a powerful method that 
involves a very precise measurement of DNA content based on the ability to stain the DNA in 
a stoichiometric manner (Ormerod, 2008). Cell cycle analyses can be also conducted based 
on the histogram outputs once it plays the distribution of cells in the different phases of the cell 
cycle (Figure 8). 
 
 
 
  
Figure 7. Cell cycle checkpoint pathways impinging upon the cell division cycle. Illustration from Chin and Yeong, 
2010. 
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II.2.5 Flow Cytometry – FCM  
Flow cytometry is a system of quantitative single cell analysis, over the time the FCM, 
especially in the biological area, has become an essential tool to perform important advances 
in biomedical research, diagnosis, and therapy (Scheffold and Kern, 2000). The equipment 
consists of five main components: a source of light (laser); a flow cell (where cells are 
suspended in the sheath fluid); optical components; electronics to amplify and process the 
resulting signals and finally a computer (Chapman, 2000) (Figure 9). 
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Figure 8. Histogram of cell cycle. Distribution of the cells in different phases of cell cycle.  
Figure 9. Schematic of a flow cytometer. (Riley and Idowu, 2009) 
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The power of single cell analysis is the ability to measure multiple parameters 
simultaneously on each individual cell. The cell shape, surface topography, membrane, 
nucleus and granular material all affect the scattering of light in the instrument. Light scatter is 
collected at two angles: forward scatter (FS) and side scatter (SS). Forward scatter is a 
measurement of the forward direction and is proportional to cell surface area or size. Moreover, 
SS is collected at approximately 90 degrees from the laser's path and is proportional to cell 
granularity or internal complexity (Nunez, 2001; Ormerod, 2008). This instrument can perform 
several kinds of measurements such as cell counting, cell sorting, biomarker detection and 
protein quantification. In practical way, the mechanism refers as a flow system where the light 
is focused at the point of measurement. Thereby, the scattered light and fluorescence of 
different wavelengths are detected by a series of photodiodes and amplified (Ormerod, 2008). 
While a large diversity of cells is usually analysed in a short period of time, other particles, such 
as nuclei and chromosomes, can also be studied through FCM, resulting in a quantitative 
information with valid data about every analysed cell (Chapman, 2000). 
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III. Aims 
The general aim of this study is evaluate the cytotoxicity of graphene oxide in a human 
lung adenocarcinoma cell line (A549). This cell line, A549 which is commonly used in 
nanotoxicology studies (Ali-Boucetta et al., 2013; Chang et al., 2011; Fiorillo et al., 2015; Lay 
et al., 2013) it is seen as a model to in vitro studies. Herein, we also highlight that the respiratory 
track might be one of the main entry point of nano/microparticles into the body.   
The specific aims of this work are: 
 Characterization of the GO in terms of their physico-chemical properties; 
 Evaluate the effects of GO on the cell viability on the human lung adenocarcinoma cell 
line (A549) using the WST-8 assay;  
 Determine the putative ROS induction in A549 cells by GO; 
 Evaluate the effects of GO on the cell cycle progression of A549 cells;  
 Assess the GO nanoparticle uptake by flow cytometry. 
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IV. Experimental Procedures  
IV.1 Graphene Oxide Material 
Graphene oxide (GO) was purchased from Sigma-Aldrich® and the solution was 
labelled to be dispersed in H2O (4mg/mL) in a bottle of 50ml. According to product information, 
GO solution has monolayer sheets in 0.5mg/mL that were assessed by AFM and SEM.  
IV.2 Characterization of Graphene Oxide 
IV.2.1 Dynamic Light Scattering – DLS 
GO was performed by Dynamic Light Scattering (DLS). The hydrodynamic diameter 
(Dh) and polydispersity index (PdI) of the particles were measured by dynamic light scattering 
and the zeta potential was assessed by electrophoretic mobility, both measured experiments 
of DLS were carried out using a ZetaSizer Nano ZS (Malvern Instruments). Dh was measured 
in samples diluted in Mill-Q water at final concentration of (10μg/ml). Dh was also measured in 
samples diluted in complete growth medium (F12-K) at (10μg/ml) and the samples were 
incubated for 0, 2, 4 and 24 hours. Before the analysis samples were submitted to 2 cycles of 
5 minutes of bath sonication (Elmasonic S60H). At the end of the incubation period, samples 
were placed in standard cuvettes and illuminated by a He-Ne laser at λ=633 nm. Three scans 
were set for each measurement. For determination of the zeta potential, GO suspension 
(10µg/mL, suspended in Milli-Q water) was transferred to a clear disposable zeta cell (Malvern, 
UK) and after equilibration to a temperature of 25°C for 2 minutes the sample was read. The 
measurement and runs were determined automatically by the instrument. 
IV.3 Cell line culture and treatment 
The A549 cell line was used for all the experiments of this study. Cells were cultured in 
75 cm2 (Corning®) culture flasks in Kaighn's Modification of Ham's F-12 Medium (F-12K) 
(Gibco), supplemented medium with 10% Fetal Bovine Serum (FBS, Gibco, USA), 1% 
penicillin-streptomycin (Life Technologies, Carlsbad, CA, USA), and 1% Fungizone (Life 
Technologies, Carlsbad, CA, USA).  
Cells were regularly seen under microscope (Nikon DS-2Mv) to check morphology, 
confluence and possible contaminants. The subculturing process was done, once the cells 
reach about 70-80% of the confluence of the flask superfice where the old medium was 
removed, and the cells were washed with phosphate buffered saline – PBS (Gibco). To 
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detached the cells from the flask or plate was used 0,25% trypsin-ethylenediaminetetraacetate 
(EDTA) solution as treatment, the cell then were resuspended and counted using a 
hemocytometer. Finally, the desired number of cells were seed to a new flask with the right 
proportion of the supplemented F-12K medium. The cells were incubated at 37°C and 5% CO2. 
The subculturing process was performed two or three days per week, depending of the required 
desired confluence. Standard aseptic techniques were followed throughout the experiments. 
IV.4 Cell Viability Assay: WST-8  
Cell viability was assessed by Cell Counting Kit-8 Assay (Sigma-Aldrich). Preliminary 
assays were performed in order optimize the WST-8 assay, where different cell densities were 
chosen and analysed (5X10³ and 10X10³cells/ml) without GO treatment. The incubation time 
with WST-8 solution was also tested at 1h, 2h, 3h, and 4h. 
The protocol of WST-8 was conducted as follow, with some modifications. One hundred 
μl of suspended cells at the concentration of 7X10³cells/ml, were seeded in 96-well plate and 
incubated for 24h for adhesion. Once they were adhered, the culture medium was taken out 
and replaced by 100μl of GO in different test concentrations (10, 50, 100, 150 and 200μg/ml) 
in complete growth medium F12-K. Seeded cells in the medium without adding GO were taken 
as control. After 24h of incubation, the GO-exposed cells and the control were washed with 
50μl of phosphate buffered saline – PBS (Gibco). Then100μl of complete medium F12-K with 
10μl of CCK-8 solution were added to each well. The cells were incubated in the normal 
condition until reading. Lastly, the samples absorbance was measured by a Microplate Reader 
(Synergy BioTek ®– Gen5™ software) at 450nm with blank and background corrections. 
In order to check the absorption of culture medium by GO on the toxicity, the protocol 
described by Chang et al., 2011 was followed with minor modifications. The GO samples (10, 
50, 100, 150 and 200μl/ml) were incubated in supplemented medium F12-K without cells at 
the same normal culture condition for 24h. Then, the culture media with GO samples were 
centrifuged at 5000rpm for 5 minutes to remove most GO. The GO-free supernatants were 
collected and introduced to A549 cells (7X10³cells/well) seeded in the 96-well plate. After 24h 
of incubation, the cell viability was assessed by WST-8 solution.  
IV.5 Determination of Reactive Oxygen Species 
The formation of intracellular ROS was measured by using the 2’-7’-
dichlorohydrofluorescein diacetate (DCFH-DA) as probe. A549 cells (10x104) were seed in 6-
well culture plates and allowed to attach for 24 hours in normal condition. Subsequently, the 
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cells were treated with 10, 50 and 150μg/mL of GO. After 24h of incubation, cells were washed 
with 1ml of PBS and 1ml of F12K medium containing 10μM of DCFH-DA was added in each a 
blank sample was provided where no probe was added. Then, the cells were incubated for 30 
minutes at 37°C and then washed with 1mL of PBS in order to eliminate the excess of the 
unreacted probe. The cells were trypsinized and finally collected to cytometry tubes, stored in 
ice and read in the follow 45 minutes. Flow Cytometery was used to measure the fluorescence 
of the intracellular reduced DCFH-DA molecules, which is directly related to the intracellular 
ROS level. Acquisitions were made using Attune® Acoustic Focusing Cytometer (Applied 
Biosystems). ROS production was estimated from the mean fluorescence intensity of DCF by 
using the FlowJo software.  
IV.6 Cell Cycle Analysis 
Cell analysis was evaluated by flow cytometry according to the method described by 
Oliveira et al., 2014. Cells were seeded (10x104) at 6-well plates for 24h in order to allow 
adherence, at normal culture conditions. Afterwards, culture medium was replaced for the 
equivalent amount of GO concentrations (10, 50, 150µg/ml), diluted in complete growth 
medium (F12K) and incubated for 24h. At the end of the exposure period, cells were trypsinized 
(300µl trypsin-EDTA solution), and transferred to microtubes. The suspensions were 
centrifuged at 700g during 5 minutes and carefully resuspended in 1ml of cold ethanol 85% for 
fixation and stored at -20°C until further analysis. To cell cycle analyses, cells were centrifuged 
at 3000rpm for 6 minutes, resuspended in 800μl of PBS and filtered through a 55 μm nylon 
mesh to remove big clusters. Subsequently, 50μl of propidium iodide (PI) from Fluka, (USA) 
and 50μl of RNAse were added (Sigma Aldrich, USA) were added to stain nuclear DNA and 
remove RNA from the samples, respectively. Samples were incubated for 15 minutes in the 
dark and read in the Attune® Acoustic Focusing Cytometer (Life Technologies). Data was 
analysis with the FlowJo Software. 
IV.7 Intracellular uptake  
Intracellular uptake assay was performed following the Suzuki, Toyooka, & Ibuki, 2007 
protocol with some adjustments. Cells were seeded (10x104) at 6-well plates for 24h in order 
to allow adherence at the normal culture conditions in three independent assays. 
Subsequently, culture medium was replaced for the equivalent amount of GO concentrations 
(10, 50, 150µg/ml), diluted in complete growth medium (F12K) and incubated for 2h, 4h and 
24h in different temperatures (4°C and 37°C). At the end of the exposure period, cells were 
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trypsinized (300µl trypsin-EDTA) and the cell suspension were resuspended and collected to 
cytometer tubes. The degree of cell uptake or adsorption on to the cell membrane was 
analysed using forward scatter (FS) vs side scatter (SS) by Attune® Acoustic Focusing 
Cytometer. Data was analysis with the FlowJo Software. 
IV.8 Statistical analysis 
Independent assays were performed for each assay. Data were expressed as mean ± 
standard deviation (SD). One-way ANOVA was performed using Sigma Plot software, version 
12.0 in order to evaluate the statistical significance between the control and the exposed cells, 
followed by the Dunnet test. Normality was verified by the Shapiro-Wilk test. 
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V. Results 
V.1 Characterization of GO 
V1.1 Zeta Potential 
The results from zeta potential measurements of GO (Table 2) shows an increases from 
-41,43mV in water to -8,42mV in F12-K culture medium. As the particles have a negative 
surface charge by nature, they attract positive charges in both solutions leading to an increase 
in zeta potential. 
 
 
 
 
 
 
 
 
V1.2 Size distribution and Polydispersity Index (PdI) 
DLS was assessed in order to evaluate the size distributions and the values of 
polydispersity indexes (PdI) of GO in growth medium and in water. The values of PdI were 
above 0.5 in all cases, and after the incubation time was observed an increase on the PdI, 
reaching at 24h, 0.922, indicating a high polydispersity of graphene oxide. 
DLS measurements for hydrodynamic diameter in complete F12K culture medium were 
obtained with the lowest concentration of GO (10µg/mL) after incubation for 0h, 2h, 4h and 24h 
(table 3). The particles suspended in water at time 0h, showed only 2 peaks and the size (by 
intensity) was 1220.15nm while the average size of GO dispersed in culture medium, exhibited 
3 peaks which presented size between 180.84nm and 399.64nm with diversity. It was 
observed an increase on the size distribution from 2h to 24h in the medium (F12K) suspension 
(figure 10). The Z-average size (by intensity) of GO dispersed in Milli Q water showed only 2 
peaks with maximum at 1863.4nm (76%) and minimum at 576.9nm (24%) while in the samples 
dispersed in growth medium, they exhibited 3 peaks in all the measurements (Figure 11). The 
largest peak, showed in zero hour, was at 832.40nm, consisted of ~63% and the two others 
peaks were 478.1nm (34%) and 18.4nm (%) of the total volume (table 3). 
 
GO (10µg/ml)  (mV) 
in MilliQ water -41.43 ±0.87mV 
in F-12K -8.42 ±0.12mV 
Table 2. Zeta Potential of graphene oxide in the 
culture medium and MilliQ water. The samples were 
analysed by DLS and the data are expressed as 
means ± SD of three different scans. 
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Hydrodynamic diameter (nm) 
Sample Time PdI Peak 1 Peak 2 Peak 3 
MilliQ water 0h 0.595 576.9 nm (24%) 
1863.4 nm 
(76%) 
- 
F12-K medium 
0h 0.730 478.1 nm (34%) 832.4 nm (63%) 
18.4 nm 
(1%) 
2h 0.820 512.8 nm 23.0 nm 6.7 nm 
4h 0.921 649.1 nm (96%) 19.3 nm 5.5 nm 
24h 0.922 428.8 nm 479.4 nm 7.3 nm 
Table 3. Average hydrodynamic diameter (intensity) of GO and the polydispersity index (PdI) values. Graphene oxide diluted in 
water and F12-K medium (10µg/mL).  
0h 0h 2h 4h 24h
GO 10ugml 1220,15 399,64 180,84 224,63 305,14
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Figure 10. Size distribution of GO (intensity). Samples were suspended in Milli Q water and F12-K medium at 
concentration of 10µg/ml and assessed by time (0h, 2h, 4h and 24h) the z-average size through DLS. Data are 
expressed as mean ± SD. 
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Size distribution by number was also generated in order to extract more information 
(Figure 12). As it shows, there is noticeable difference between the water and medium 
suspension, the size distribution of GO (10µg/ml) in Milli Q water was found an average 
hydrodynamic diameter of 885.4 ±147.1nm while in the growth medium (F-12K) was found an 
upsurge of the z-average with the increase of the incubation time from 549.8 ±134.8nm at zero 
hour to 1332.4 ±428.2 nm at 24 hours. 
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Figure 12. Size distribution (number) of GO in Milli Q water and (*) F-12K medium at concentration 
of 10µg/ml according to incubation time. Data are expressed as means ± SD.  
Figure 11. Size distribution (by intensity) report of DLS measurements. A. GO dispersion in Milli Q water (0h) and B. GO 
dispersion in F12-K medium. 
A 
B 
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V.2 Morphology of A549 
A549 human lung cancer cells are adherent cells that grow in monolayer and exhibit 
typical cuboidal epithelial aspect, under normal culture conditions. Once seeded, the cells start 
to grow in colonies that eventually reach each other; the flask or plate is considered fully 
confluent when the entire surface is covered with cells (Figure 13). 
 
GO concentrations of 10 µg/mL, 50 µg/mL, 100 µg/mL, 150 µg/mL and 200µg/mL were 
chosen to be exposure to A549 cells. After exposure to GO for 24 hours, the cells were 
observed, and at the lowest concentration (10µg/mL) the cells seem to grow normally but an 
agglomeration of GO on the medium is observed covering partially the cell surface. The 
aggregation of GO in the culture medium increases with the rise of GO concentration (figure 
14). Regarding the morphology of the cells, after the GO exposure (24h), the cells were 
observed before and after the washing process with PBS, once all the GO aggregates are 
rinsed from the well, the normal morphology can be observed, as it shows in Figure 14.C (up 
right) the GO concentration 150 µg/mL before and after the washing process. 
Figure 13. Light microscopy images of A549 cells. Confluence surface of A549 cells; left: cells at 10X 
magnification; right: cells at 40X magnification. 
Figure 14. Light microscopy images of A549 cells exposed to GO after 24h. A - control cells; B - 10µg/mL; C - 150µg/mL before and after 
the washing process with PBS, shown the after washing process in the upright image. Insert at 10X magnification. 
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Figure 12. Light 
microscopy 
images of A549 
cells. A - control 
cells; B - 
10µg/mL; C - 
150µg/mL. Insert 
at 10X 
agnification.C 
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Figure 12. Light 
microscopy images 
of A549 cells. A - 
control cells; B - 
10µg/mL; C - 
150µg/mL. Insert 
at 10X 
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V.3 Cell Viability – WST-8   
A preliminary WST-8 assay was performed with different cell densities without GO, in 
order to find the most suitable cell density (5x10³ and 10x10³) and also to select the incubation 
time (1h, 2h, 3h and 4h) with WST-8 reagent. As shown in the figure 15, the absorbance results 
through the time and cell densities had different response without any treatment, what shows 
the increasing of the absorbance, reaching the highest value for both populations at 2h of 
incubation. The information about the times 3 and 4 hours are not shown, because 
the absorbance was overflow, meaning the reading was outside of the dynamic range.  
The potential cytotoxicity of GO was then evaluated with WST-8 assay in several tests, 
initially two different cell densities were measured (5x10³ and 7x10³), and the 7x10³ cell density 
was chosen to be assessed in the following procedures of cell viability.  
At the beginning of the study, the WST-8 assay was performed by adding directly the 
WST-8 solution (10µl) to the culture medium with the different concentrations of GO at the 
different concentrations after 24h, a blank correction and also a background were performed 
by subtracting the absorbance of the culture medium to the respective GO concentration. The 
results, showed toxicity response as dose-dependent, reducing the cell viability. A significant 
reduction of 80% of cell viability was found at the highest concentration (200µg/mL) while at 
the lowest concentration no decrease was found, being almost equal to control cells (figure 
16). Also an important observation on the GO behaviour (background samples) was found, 
regarding GO and the WST-8 reagent. It showed an increase on the absorbance, as is 
indicated by a green arrow in the figure 16. 
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Figure 15. Optimization of WST-8 assay. Performed with 2 cell densities (5x10³ and 
7x10³); the incubation time were 1h, 2h and 3h and 4 h (data not shown). 
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Observing those results, in which the toxicity of GO seems to be overestimated, 
putatively by an interference of GO with the WST-8 assay. Therefore, in order to reduce that 
supposed interference, an additional washing step was included to the protocol. In more detail, 
after the 24h exposure with GO, cells were washed with PBS and after that new culture medium 
with only WST-8 reagent, was added to all wells. Results of this WST-8 assay are considerably 
different of the previous ones (Figure 17), in which only a slight decline in cell viability was 
detected with the increase of GO concentration, but in the highest concentration (200µg/ml) 
the cell viability was still ~86%, however the differences did not reach the statistical 
significance. 
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Figure 16. WST-8 assay was performed after A549 cells (7x10³) were exposed for 24 hours to GO. The cells were not submitted to the PBS 
washing step in this assays (n=3). The green arrow indicates the absorbance found on the GO and WST-8 reagent only. Data is showed as 
mean ±SD. 
Figure 17. Cell viability of A549 cells exposed to GO in 
increase concentrations. WST-8 assay was evaluated 
and statistical analysis was performed with ANOVA. 
Means ±SD n=3.  
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In order to evaluate the absorption of culture medium nutrients by GO and if it influences 
the toxicity, a new set of WST-8 experiments were performed as it is mentioned in the last 
section. The results did not show any statistically significant difference, however a trend to a 
decrease in cell viability was observed to the cells exposed to culture medium incubated with 
GO (P<0.05) (Figure 18).  
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Figure 18. Cell viability assay of A549 cells 7x10³ exposed to GO-free medium 
in increase concentrations. WST-8 assay was evaluated and statistical analysis 
was performed with ANOVA (p<0.05). Means ±SD n=2. 
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V.4 Determination of Reactive Oxygen Species 
The quantification of intracellular ROS in A549 cells exposed to GO for 24h is presented 
in Figure 19. GO induced the production of ROS reaching a significant 1.6 ±0.19 fold increase 
at 37µg/mL, compared to control cells. The ROS levels at the highest concentration (150µg/mL) 
were 0.8 ±0.2 representing a slight reduction compared to control cells. There was a statistically 
significant difference (P=<0.001) at 10 and 37µg/mL.  
  
Figure 19.  Level of intracellular ROS upon exposure to GO. A549 cells were exposed 
to increasing concentrations of GO and measured by FCM. (*) shows the statistically 
significant difference (P<0.001). Data shows means ±SD 
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V.5 Cell Cycle Analysis 
After 24h exposure to GO at 10, 37, 50 and 150μg/mL, A549 cells were collected to 
perform cell cycle analysis and the global cell cycle stages are showed in figure 20.  
The number of counted nuclei was plotted against the intensity of fluorescence detected 
in BL2-A in the FCM; where the intensity of fluorescence is proportional to the amount of PI 
bound to the DNA. The boundaries of the peaks were set using the FlowJo software to 
differentiate nuclei in the G0/G1, S and G2/M phases using the Dean jet Fox model. At 
concentration 50µg/ml, a statistically significant decrease in the percentage of cells in S phase 
and an increase in the percentage of cells in G2 phases was found with P<0.001 (Figure 19).  
 
 
Exposure to higher lower concentrations of GO did not induce any alterations to the cell 
cycle of A549 cells, as another way to visualize the results, the figure 21 shows the distribution 
of the cells, by phase, combining all the GO treatment by phase. Also histograms from the 
control and GO (50µg/ml), are shown, as it was the only concentration found a statistically 
significant difference.  
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Figure 20. Cell cycle results of A549 GO exposure after 24h. The given results are the mean % of cell population (±SD) along cell cycle stages. 
(*) shows the statistically significant difference (P=<0,001) with Multiple comparisons versus control groups. 
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Figure 21. Percentage of cells in each phase of the cell cycle upon exposure to GO for 24h. where (*) 
shows the statistically significant difference with P<0.05. Histograms are show from control cells and GO 
(50µg/ml) treated cells. 
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V.6 Uptake of GO 
The uptake of GO was analysed using by evaluating the changes in side scatter (SS) 
by FCM. Cellular uptake of GO was measured after 2h and 4h incubation at 37°C/4°C and also 
after 24h incubation at 37ºC. The results of 2h of incubation at 37ºC showed an increase of SS 
intensity at 150µg/mL, and statistically significant difference was found (P<0.05). When 
incubated at 4ºC, for the same time of incubation (2h) the concentration 50µg/mL exhibited 
statistically significant difference (P<0.05) with a variation in the SS intensity. The results for 
24h of incubation at 37°C did not demonstrate any statistically significant difference when 
compared against the controls (figure 22). 
 
  
Figure 22. Uptake of GO in A549 cells incubated at 37°C (left hand side) and 4°C (right hand side). (*) shows the statistically significance difference 
found upon exposure to GO (P<0.05). means ±SD, n=2.  
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VI. Discussion 
Graphene oxide has shown a promising future for many applications in several fields. 
Once the potential for exposure to nanomaterials has been increasing in the everyday life, the 
safety level has been an issue to concern, as the behaviour of nanoparticles in biological 
systems is not yet fully understood. In this study, the cytotoxic potential of the graphene oxide 
(GO) was assessed in adherent human lung adenocarcinoma cell line (A549), as inhalation is 
considered one of the main entrance routes of nanoparticles in the organism (Card et al., 2008; 
Itoh et al., 2004; Sanchez et al., 2013). Therefore, several endpoints were evaluated, namely 
the cell viability using the WST-8 assay, the production of reactive oxygen species, the cellular 
uptake and, also, the effects on the cell cycle dynamics. Some studies have already reported 
the toxicity of GO in vitro, in different cell lines, and in vivo, however, many inconsistencies in 
the results were detected.  
The zeta potential results show that GO in water carried a strongly negative surface 
charge (-41.43mV) that considerably increased in F12-K medium towards neutrality, reaching 
-8.42mV. Since most cellular membranes are negatively charged, the charge of the particle is 
determinant for the nanoparticle’s tendency to permeate membranes. It was also observed that 
GO in water solution was well dispersed, and that highly negativity found is due to the 
abundance of carboxyl groups on its surface (Shen et al., 2012). The GO in culture was prone 
to quick aggregation, due to the low zeta potential, and for that reason samples were bath-
sonicated before the measurement of the average hydrodynamic size. After that, a decrease 
in Dh in time 0 was observed for GO in medium (399.64nm), comparatively to GO in water 
(1220.15nm). However, the size of GO particles in F12K medium showed a tendency to 
increase from the 2h to 24h (180.84nm to 305.14nm), showing that GO might increase the 
average Dh in a biological environment through the time. Knowing that the F12-K is rich in 
salts, nutrients and most important, electrolytes and chlorides, these components may interfere 
with size and stability of any nanoparticle. As GO is not a spherical particle, the DLS 
measurement cannot give accurate results for those particles  (Lammel et al., 2013), 
alternatively electronic microscopy (SEM and/or TEM) could be use in order to characterise 
the samples. 
In order to assess the effect of GO in the cell viability, a range of concentrations of GO 
were chosen (10µg/mL to 200µg/mL). WST-8 viability assay was performed in A549 cells since 
this assay is recommended  to check the cell viability in carbon nanoparticles (Monteiro-Riviere 
and Inman, 2006). Moreover, other authors have performed this assay with different cell lines 
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and graphene nanoparticles such as: erythrocytes and fibroblast (Liao et al., 2011; Wang et 
al., 2010); breast cancer cell - MCF-7 (Gurunathan et al., 2013); BT-20 (Shim et al., 2015); U87 
MG cells (Zhou et al., 2014); human bone marrow neuroblastoma-SK-N-SH and human 
epithelial carcinoma-HeLa (Chen et al., 2012). Furthermore, Liao et al. 2011 studied the 
interference between the WST-8 and MTT assays and graphene nanomaterials and found that 
MTT reacted with the nanoparticles (GO and Graphene sheets) producing MTT purple 
formazan without cells. Also, the lactate dehydrogenase (LDH) assay was checked in the same 
study and the test generated underestimation results, leading to a false positive (Liao et al., 
2011). A previous study by (Chang et al., 2011) verified viability loss provoked by GO, they 
selected different sizes (m-GO; s-GO; l-GO) and GO concentrations (10µg/mL from 200 
µg/mL), Chang and co-workers, mentioned that the size of the nanoparticle is another factor 
that will influence cell viability, as in their work, the smallest GO particles were the most 
cytotoxic, reducing the cell viability in 33% after 24h of exposure. Herein our data, a trend to a 
dose dependent decrease in cell viability was also observed, however at the highest 
concentration (200µg/mL) the cell viability was 86% and no statistically significant difference 
was found. Another relevant study also reported that cell viability can be noticeably reduced as 
the synthesis method used to produce GO changes (Lay et al., 2013). Lay et al. 2013 assessed 
the four most common GO preparation methods (oxidative treatments) and the cell viability 
visibly reduced and showed dose-dependence. The authors reported the relation between the 
amount of Oxygen-containing groups (C/O ratio) with the loss of viability, as they found, that 
as higher the amount of C=O, the highest loss of viability and as less amount of C=O, the less 
cytotoxic effects on the cells. 
Regarding the time of exposure, Chang et al. 2011 also comment that for cell viability, 
time does not seem relevant, as they checked at 24h, 48h and 72h and similar results were 
found for their experimental conditions (Chang et al., 2011). In this study the chosen time to 
GO exposure to A549 cells was 24h at all the assessed experiments. The adsorption of the 
culture medium by GO also was performed to see if the material would be captivating through 
any way to growth medium after 24h of exposure and no interference was found). Overall, the 
results did not show any statistically significant difference in the cell viability assay. 
To proceed with the next assays, we used a very effective technique, flow cytometry 
(FCM) which is well recognized for perform measurements with precision and speed, being 
used for instance to measure oxidative stress, (Amer et al., 2003; Eruslanov and Kusmartsev, 
2010) to analyse the cell cycle (Oliveira et al., 2014), and more lately has been used in some 
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studies to investigate the cellular uptake through the light scattering (side and forward scatter- 
SS and FS) (Suzuki et al., 2007).  
In terms of ROS production, in this study, we explored the generation of ROS using 
DCFH-DA probe with FCM technique. A complex antioxidant system has been developed to 
relieve oxidative stress, as a natural ability in biological systems to detoxify the cells, in order 
to repair a possible damage in the organism, as many studies have demonstrated, oxidation 
represents a common mechanism to explain the damage of nanomaterials (Adjei et al., 2014; 
Buzea et al., 2007; Lewinski et al., 2008; Lu et al., 2011; Tang et al., 2015). Thereby, the ROS 
generation by GO have been evaluated and most of the studies show that this nanomaterial 
has high potential to induce ROS production even at low concentrations (Chang et al., 2011). 
Our data confirms that information, when shows a significant increase in ROS levels at the 
lowest GO concentrations assessed (10ug/mL and 37ug/mL). On the other hand, at the highest 
concentration of GO (50ug/mL and 150ug/mL) ROS levels decreased to levels similar to the 
control, suggesting that A549 cells may have neutralized the amount of ROS produced through 
enzymatic reactions (Liang et al. 2013).  
The cell cycle dynamics in terms of percentage of cells in the three main phases (G1, S 
and G2) was also evaluated by FCM. Our results suggest that GO at 50ug/mL induced 
alterations in cell cycle dynamics of A549 cells, namely in S phase and G2 phases. Previous 
studies also observed cell cycle arrest at G2 phase after exposure to carbon nanomaterials 
(SWCNTs) (Yuan et al., 2011), and alterations in cell cycle dynamics after exposure to GO 
(Matesanz et al., 2013). The arrest in the G2 phase may indicate that cells are attempting to 
repair damage or some related misleading of DNA. Then, under the other GO concentrations 
any significantly changes in cell cycle were detected, even the highest concentration assessed 
(150ug/mL), which also confirms that GO did not cause any significant toxicity to the cell growth 
and proliferation (Yan et al., 2012; Yuan et al., 2011). Overall, the slight variations showed in 
this study on the cell cycle dynamics of GO-treated cells confirms the low cytotoxicity of GO as 
previously suggested (Ryoo et al., 2010). 
Next, in order to evaluate whether the absence of toxicity of GO nanoparticles was due 
to the inability to readily enter cells, the cellular uptake of GO at 37°C and 4°C was measured 
by FCM. The cellular uptake in A549 cells showed that there was an increase in the SS intensity 
found at 150ug/mL concentration with a statistically significant difference comparatively to the 
control. After the same period (2h) when endocytosis was inhibited (at 4°C) there was a 
statistically significant difference in the SS intensity for the dose 50µg/ml indicating that the 
nanoparticles were internalized. In our results, the cellular uptake of GO was not time 
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dependent, once in a relatively short period of incubation (2h) the SS intensity of the highest 
concentration of GO was increased.  
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VII. Conclusion and Future Perspectives  
In our study, GO at the range of concentrations tested, did not decrease the viability of 
A549 cells. However, GO at lower doses may interfere on the ROS production after 24 hours, 
while at higher doses the ROS levels were similar to those of the control. Concerning the cell 
cycle dynamics, GO at 50ug/mL induced a decrease in the percentage of cells at S phase and 
an arrest at G2, what can suggest that the cells are attempting to repair damaged DNA. Our 
results indicated that the nanoparticles may have been internalized after 2h at 150ug/mL 
(37°C). In general, GO did not show any obvious toxicity to the cells A549, as morphologically 
they were considered growing normally after the exposure time, however variations were found 
in our results and considering the promising applications in a very large range of fields of the 
material, attention must be taken to further analyse the relationship between graphene oxide 
and lung cells.  
To better understand the physicochemical characteristics of GO in culture medium, 
future studies should include a more detailed characterization of GO nanoparticles. 
Furthermore, to fully understand the biological effects of GO to lung cells, future work could 
entail genotoxicity assessment by, for instance, the evaluation of DNA damage by the comet 
assay. Finally, considering the role of graphene and its derivatives in the nanotechnology field 
in the lastly years, the importance of keeping the further investigations with fundamental and 
experimental research must be highlighted. 
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